In this study, we describe the characteristics of TMB and PD-L1 TPS in various hematologic malignancies and explore their prognostic value.1,2,4, –6,32 We noted that the TMB in hematologic malignancies tends to be low, especially among the myeloid malignancies. This evidence concerns the gene CD274 and myeloid neoplasm.